| About Us |
| News & Events |
| Research |
| Publications |
| Affiliates |
| Cores |
| Other Resources |
| Useful Links |
| Contact Information |
| News & Events Archives |
| Copyright © 2009 by the President and Fellows of Harvard College |
NERCE is a network of research
collaborations that supports basic
science and translational research
for the development of therapeutics
and vaccines against current and
emerging infectious disease threats. More... |
|
New Publications:Lee K, Campbell J, Swoboda JG, Cuny GD, Walker S (2010). Development of improved inhibitors of wall teichoic acid biosynthesis with potent activity against Staphylococcus aureus. Bioorg Med Chem Lett [Epub 2010 Jan 20] PMID: 20138521 Gening M, Maira-Litran T, Kropec A, Skurnik D, Grout M, Tsvetkov YE, Nifantiev NE, Pier GB (2010). Synthetic {beta}-(1->6)-linked N-acetylated and non-acetylated oligoglucosamines to produce conjugate vaccines for bacterial pathogens. Infect Immun [Epub 2009 Nov 30]. PMC Journal - In Process. Guo Y, et al. (2009). Identification of a new region of SARS-CoV S protein critical for viral entry. J Mol Biol 394(4):600-5. PMC Journal - In Process. König R, et al. (in press). Human host factors required for influenza virus replication. Nature. doi:10.1038/nature08699 (advance online publication 21 Dec 2009). Brass AL, et al. (2009). The IFITM Proteins Mediate Cellular Resistance to Influenza A H1N1 Virus, West Nile Virus, and Dengue Virus. Cell 139:1243-1254 |
Terrence Tumpey |